I meant to say UK citizens as well I read it wrong. Sorry!Got an email from them. They only take US citizens. Why do they have trials in London then??
Looks like we are closing in on a potential cure on multiple flanks.
Yawn. Hyped headline. No new information. Phase 1 was successful, recruiting for phase 2.
I know, just thought I'd share that there were some press about it.Yawn. Hyped headline. No new information. Phase 1 was successful, recruiting for phase 2.
Might be kind of hard when they ask to see your passport.You would probably be able to just give them a fake address, I doubt they're going to look through your credit records or electoral register to verify your identity.
Within the next two years surely we'll know whether we are or not.Looks like we are closing in on a potential cure on multiple flanks.
My understanding is you just need to be a resident, not a citizen. Almost half of London where the trial is are not British citizens.Might be kind of hard when they ask to see your passport.
As per Audion therapeutics:Within the next two years surely we'll know whether we are or not.
The results of the phase I and II REGAIN studies will be published after the completion and data analysis of both studies; we are aiming for early 2020.
=> It means they believe it could still work after 20 years of damage, that's a very good sign.Thank you for your interest in our trial. We have recently broadened the inclusion criteria for participants with hearing loss of up to 20 years duration. If you are interested in taking part, please contact the REGAIN trial team by telephone: 020 3108 9344 or by email: ei-regain@ucl.ac.uk.
The drug we are testing in the REGAIN trial is aimed at regenerating inner ear hair cells and restoring hearing in people who have acquired hearing loss later in life. With hearing loss and tinnitus closely linked, we will be monitoring the effect of the drug on tinnitus as well. Worldwide trials of novel drugs for tinnitus are being initiated; it is too early to tell if they will cure tinnitus.
Dear Alex, thank you for your question. Any potential participant with a history of exposure to ototoxic agents, for example, aminoglycoside group of antibiotics or chemotherapy agents (cisplatin) in the last 12 months would not be eligible to participate in the trial. However, if exposure to the ototoxic agents occurred prior to the specified time-period, then participants may be eligible to participate in the REGAIN clinical trial.
From @síocháin's post it seems to be that it doesn't since the musician was able to play music again. If this is actually true and this person did get his tinnitus and hyperacusis reduce I believe FX-322 can do the same thing.This may have been written before. While I was waiting in an hospital for a ent appointment a few weeks ago, I read a notice on the wall about the Regain project. They were looking for volunteers but they said explicitly that if one was bothered more by tinnitus then by hearing loss then this person would not have been suitable. This bothers me. Could the treatment worsen tinnitus?
I think they didn't want to muddy the waters too much. Their focus is on hearing loss. Someone asked them if there was a chance that their drug could cure tinnitus. Their response:Could the treatment worsen tinnitus?
The rumour in the music community here was this person was doing much better with his tinnitus and hyperacusis and could work with music again like before. I managed to get in contact with him and turns out he has been a part of the Regain Project trials.
He said he unfortunately wasn't allowed to tell me much about it, but that he had some gel-like medicine injected in his ears, and it had helped him a lot. He used those words!
And also I see he is touring again, which really is a good sign!
Just wanted to post it on the forum, cause it sure made me hopeful for some relief in the near future!
The drug isn't a gel-like substance, it's a liquid:
"This is the first time the study drug LY3056480 will be tested in people. The study drug is a liquid that must be delivered to the inner ear, through the eardrum using a syringe."
It almost has to be a gel. If it was a low viscosity liquid it would immediately flush out through the eustachian tubes without plugging them first.I think these are irrelevant semantics. There are also products that call themselves "liquid gel". What is that then?